Loss of TRIM62 Expression Is an Independent Adverse Prognostic Factor in Acute Myeloid Leukemia

TRIM62 is a putative tumor suppressor gene. We investigated the levels of expression of TRIM62 protein in 511 patients with acute myeloid leukemia (AML) by reverse-phase protein array technology. Low TRIM62 levels were associated with markedly poorer outcomes and improved the prognostic impact of NP...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Clin Lymphoma Myeloma Leuk
Asıl Yazarlar: Quintás-Cardama, Alfonso, Zhang, Nianxiang, Qiu, Yi Hua, Post, Sean, Creighton, Chad J., Cortes, Jorge, Coombes, Kevin R., Kornblau, Steven M.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2014
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4560255/
https://ncbi.nlm.nih.gov/pubmed/25248926
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clml.2014.07.011
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller